BioMarin Pharmaceutical Inc
LSE:0HNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioMarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
U
|
US Bancorp
DUS:UB5
|
US |
|
Q
|
Quest Diagnostics Inc
XMUN:QDI
|
US |
|
P
|
Philip Morris International Inc
XMUN:4I1
|
US |
|
C
|
Compass Inc
NYSE:COMP
|
US |
|
Northern Technologies International Corp
NASDAQ:NTIC
|
US |
|
3
|
3i Group PLC
OTC:TGOPF
|
UK |
|
A
|
Alaska Air Group Inc
LSE:0HC3
|
US |
|
Recruit Holdings Co Ltd
OTC:RCRRF
|
JP |
|
Q
|
Qualcomm Inc
XMUN:QCI
|
US |
|
Ping An Insurance (Group) Co of China Ltd
F:PZXB
|
CN |
|
G
|
Graham Holdings Co
DUS:WPOB
|
US |
|
Dabur India Ltd
BSE:500096
|
IN |
|
Z
|
Zoetis Inc
SWB:ZOE
|
US |
Bankruptcy Probability
BioMarin Pharmaceutical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioMarin Pharmaceutical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
BioMarin Pharmaceutical Inc
NASDAQ:BMRN
|
11.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioMarin Pharmaceutical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioMarin Pharmaceutical Inc has total debt of 3.5B USD. This includes both short-term (0 USD) and long-term (3.5B USD) debt.
You can find a full breakdown on its Balance Sheet.